VEGFA and wet macular degeneration: Current treatment strategies for patients with wet AMD focus on reducing the intraocular concentration of free VEGF through repetitive monthly injections of anti-VEGF agents, a treatment paradigm that imposes a substantial medical and economic burden on the patient.